Prevena Central for plastic surgery

The Power to Protect with 3M™ Prevena™ Therapy

Request a Trial

Prevena Therapy is designed to manage and help protect the surgical incision and reduce the risk of surgical site complications to improve patient outcomes across multiple surgical specialties.^1-11 This can also help to reduce the burden on healthcare facilities through reduced reoperations ^2,5,8 and associated additional costs of treatment.^10,11,

Prevena Therapy demonstrates reduction in Surgical Site Complications (SSCs) vs Standard of Care (SOC)

In a prospective, single-center, randomized controlled trial with patients undergoing breast reconstruction, Prevena Therapy aided in:

Reduction in SSCs^8*

90-day post-operatively
8.5% (28/331) Prevena Therapy vs.
15.9% (53/334) SOC (p=0.0092)*
Reduction in SSIs^8*

90-day post-operatively
2.1% (7/331) Prevena Therapy vs.
4.5% (15/334) SOC (p=0.0225)
Reduction in seroma^8*

90-days post-operatively
1.8% (6/331) Prevena Therapy vs.
5.7% (19/334) SOC (p=0.0106)*

Calculations are derived based on relative patient group incidence rate reported in this study.

*Statistically significant (p<0.05).

Jump to:

Proactive Risk Management (PRM) with Prevena Therapy

Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in plastic surgery.

Download the Clinical Evidence Summary on the use of Prevena Therapy in Plastic Surgery

Prevena Therapy is supported by more than 200 peer reviewed publications, with more being published every year. Download our easy to digest summary of the relevant clinical and health economic evidence to support the use of Prevena Therapy in Plastic Surgery.

Download Clinical Evidence Summary
Patient and procedure risk stratification

Prevena Therapy can benefit all surgical patients, but choosing Prevena Therapy for your high-risk patients can lead to improved outcomes and significant cost savings. Our Proactive Risk Management (PRM) decision guides can help you to select the right patients, and the right procedures, when using Prevena Therapy to help optimise patient outcomes.

View Risk Stratification Guide (PDF, 187 KB)

Request a trial today

Contact us to request a trial and consultation with a 3M clinical specialist

REQUEST A TRIAL

Surgeon testimonials

Peer reviewed clinical evidence

3M™ Prevena Restor™ Bella·Form Case Studies

Management of double mastectomy (PDF, 138 KB)
Bilateral breast reconstruction (PDF, 121 KB)
Bilateral nipple-sparing mastectomy (PDF, 168 KB)
3M ciNPT Clinical Compendium

With over 200 peer reviewed publications studying Prevena Therapy, there is now sufficient evidence to provide guidance to help surgeons in their decision making. The ciNPT Clinical Compendium contains evidence-based guidance for the use of Prevena Therapy for proactive risk management in a variety of specific clinical circumstances.

Download the clinical compendium

Application videos

Ready to try Prevena Therapy?

Thank you for your request to 3M. The information you provide on this form will be used to respond to your request through email or telephone by a 3M representative or by one of our authorised business partners with whom we might share your personal information consistent with the 3M privacy policy.

Please provide your information about your professional interest as we'd like to make sure you only recieve information from 3M that is interesting and relevant to you
Please choose your product of interest: (Optional)
Business Email Address
First Name
Last Name
Salutation (Optional)
City (Optional)
Post Code
Business Phone

Address 1 (Optional)
Country
Language
State or Region
Organisation Name
Department
Number of beds in your hospital (all wards)
Are you a healthcare professional?
Which health care setting are you focusing on?
Job Role
What is your main specialisation?
Subscribe to Newsletter
Data Privacy
Marketing Consent
Profiling Consent
End Devices Consent
Consent Legal Text
3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.
Submit

Our apologies...

An error has occurred while submitting. Please try again later

Thank you!

Your form was submitted successfully

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.

References

Ferrando PM, Ala A, Bussone R, Bergamasco L, Actis Perinetti F, Malan F. Closed incision negative pressure therapy in oncological breast surgery: comparison with standard care dressings. Plast Reconstr Surg Glob Open. 2018 Jun 15;6(6):e1732. doi:10.1097/GOX000000000000173
Pleger SP, Nink N, Elzien M, Kunold A, Koshty A, Boning A. Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study. Int Wound J. 2018;15(1):75-83.
Cooper HJ, Bas MA. Closed-incision negative-pressure therapy versus antimicrobial dressings after revision hip and knee surgery: a comparative study. J Arthroplasty. 2016 May;31(5):1047-1052. doi:10.1016/j.arth.2015.11.010
Redfern RE, Cameron-Ruetz C, O’Drobinak SK, Chen JT, Beer KJ. Closed incision negative pressure therapy effects on postoperative infection and surgical site complication after total hip and knee arthroplasty. J Arthroplasty. 2017;32:3333-3339. doi:10.1016/j.arth.2017.06.019
Newman JM, Siqueira MBP, Klika AK, Molloy RM, Barsoum WK, Higuera CA. Use of closed incisional negative pressure wound therapy after revision total hip and knee arthroplasty in patients at high risk for infection: a prospective, randomized clinical trial. J Arthroplasty. 2019 Mar;34(3):554-559e1. doi:10.1016/j.arth.2018
Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
Grauhan O, Navasardyan A, Hofmann M, et al. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
Gabriel A, Sigalove S, Sigalove N, et al. The impact of closed incision negative pressure therapy on postoperative breast reconstruction outcomes. Plast Reconstr Surg Glob Open. 2018 Aug; 6(8): e1880.doi:10.1097/GOX.0000000000001880
Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, Salvatore D, Reiter D, DiMuzio P. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018 Dec;68(6):1744-1752. doi: 10.1016/j.jvs.2018.05.224. Epub 2018 Aug 17. PMID: 30126781.
Gabriel A, Maxwell GP. Economic Analysis Based on the Use of Closed-Incision Negative-Pressure Therapy after Postoperative Breast Reconstruction. Plast Reconstr Surg. 2019 Jan;143(1S Management of Surgical Incisions Utilizing Closed-Incision Negative-Pressure Therapy):36S-40S. doi: 1097/PRS.0000000000005311. PMID: 30586102.

Prevena Central for plastic surgery

Reduction in SSCs8*

Reduction in SSIs8*

Reduction in seroma8*

Proactive Risk Management (PRM) with Prevena Therapy

Request a trial today

Surgeon testimonials

Peer reviewed clinical evidence

3M™ Prevena Restor™ Bella·Form Case Studies

Application videos

Product info and abstracts

Ready to try Prevena Therapy?

Our apologies...

Thank you!

References

Reduction in SSCs^8*

Reduction in SSIs^8*

Reduction in seroma^8*